Argentina vs Cambodia: Access to anti-retroviral drugs, female
Argentina
89.0%
in 2024
Cambodia
89.0%
in 2024
Argentina rank
35th
Cambodia rank
35th
Access to anti-retroviral drugs, female over time
- Argentina
- Cambodia
How they compare
Argentina currently reports 89.0% against 89.0% in Cambodia, a difference of 0.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Argentina ahead.
Argentina ranks 35th and Cambodia ranks 35th of 141 countries.
Across the 3 decades both report, Argentina averaged higher in 1 and Cambodia in 2.
Head to head by decade
| Decade | Argentina | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.5% | 15.1% | 15.4% | Argentina |
| 2010s | 61.0% | 66.8% | 5.8% | Cambodia |
| 2020s | 82.6% | 85.4% | 2.8% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Argentina or Cambodia?
- Argentina, at 89.0% against 89.0% in Cambodia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Argentina and Cambodia?
- 0.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Cambodia?
- 25 years are reported by both, from 2000 to 2024.
- How do Argentina and Cambodia rank globally for access to anti-retroviral drugs, female?
- Argentina ranks 35th and Cambodia ranks 35th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.